Organogels, hydrogels and bigels as transdermal delivery systems for diltiazem hydrochloride

被引:97
作者
Ibrahim, Mahmoud Mokhtar [1 ,2 ]
Hafez, Salma A. [1 ]
Mahdy, Mahmoud M. [1 ]
机构
[1] Zagazig Univ, Dept Pharmaceut, Fac Pharm, Zagazig, Egypt
[2] Najran Univ, Dept Pharmaceut, Fac Pharm, Najran, Saudi Arabia
关键词
Organogels; Hydrogels; Bigels; Lecithin; Span;
D O I
10.1016/j.ajps.2013.07.006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the present study, gel formulations of organogels, hydrogels, and oleo-hydrogel (bigels) were evaluated as transdermal drug delivery systems for diltiazem HCL(DH). Organogels were prepared using soya-beanoil (SO) as a solvent and span 60 (Sp60), cetyl alcohol (CA) or lecithin-pluronic (PLO) as organogelators without and with different surfactants (2% w/w) namely span 80 (Sp80), tween 20 (T20) and tween 80 (T80). On the other hand, hydrogels were formulated using Hydroxypropyl-methylcellulose (HPMC) polymer and bigels were prepared by mixing organogels with HPMC hydrogels. The prepared gels were analyzed microscopically, thermally by DTA and for pH, and viscosity. The effect of gelator used, surfactant types and pH of the sink on DH release from cellophane membrane was investigated. In addition, the DH permeability across the rabbit skin was evaluated. Finally, the in vivo performance of various gel formulations was assessed based on the hypotensive effects of the drug using hypertensive albino male rat models. The microscopical analysis indicated that the solid fibers formed by gelator particles form the backbone of the organogels while bigels appeared as emulsion like. The addition of surfactants showed an increase in organogel viscosity. The thermal analysis of organogels indicated that the drug present in amorphous not in crystalline form. The release studies indicated that DH release from organogels, hydrogels and bigels could be controlled. The included surfactants decreased the DH release and permeation from organogels compared to those without surfactants using either Sp60 or CA. HPMC hydrogel and Bigels showed higher DH release and permeation rates when compared to organogels. The percent DH released in different pH values was in the following descending order: pH5.5>pH1.2>pH6.8>pH7.4. The in vivo antihypertensive activity of DH using different transdermal gels is arranged as following: hydrogels> PLOorganogel> bigel>Sp60 organogel. (C) 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:48 / 57
页数:10
相关论文
共 41 条
[1]  
Almeida IF, 2008, PHARM DEV TECHNOL, V13, P487, DOI [10.1080/10837450802282447, 10.1080/10837450802282447 ]
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]  
Barratt, 2000, Pharm Sci Technol Today, V3, P163
[4]   SIMPLE METHOD FOR RECORDING LEFT-VENTRICULAR PRESSURE DP-DT AND HEART-RATE IN THE CONSCIOUS CAT [J].
BURDEN, DT ;
BLABER, LC ;
NATOFF, IL .
PHARMACOLOGY & THERAPEUTICS, 1979, 5 (1-3) :99-102
[5]  
CANGIANO JL, 1979, J PHARMACOL EXP THER, V208, P310
[6]   Polysaccharide hydrogels for modified release formulations [J].
Coviello, Tommasina ;
Matricardi, Pietro ;
Marianecci, Carlotta ;
Alhaique, Franco .
JOURNAL OF CONTROLLED RELEASE, 2007, 119 (01) :5-24
[7]   PULSATILE VERSUS STEADY COMPONENT OF BLOOD-PRESSURE - A CROSS-SECTIONAL ANALYSIS AND A PROSPECTIVE ANALYSIS ON CARDIOVASCULAR MORTALITY [J].
DARNE, B ;
GIRERD, X ;
SAFAR, M ;
CAMBIEN, F ;
GUIZE, L .
HYPERTENSION, 1989, 13 (04) :392-400
[8]  
DOUGLAS JR, 1976, J PHARMACOL EXP THER, V196, P35
[9]   Moist wound healing with occlusive dressings: A clinical focus [J].
Eaglstein, WH .
DERMATOLOGIC SURGERY, 2001, 27 (02) :175-181
[10]   SURFACTANTS AND EXPERIMENTAL IRRITANT CONTACT-DERMATITIS [J].
EFFENDY, I ;
MAIBACH, HI .
CONTACT DERMATITIS, 1995, 33 (04) :217-225